Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by consultant99on Mar 09, 2016 9:26am
218 Views
Post# 24638072

March 7th Presentation...

March 7th Presentation...Upcoming Milestones
  • Out licensing agreements for international markets
  • M&A transactions
We all new about the first but the second - really?

This is so playing out like the Zars fiasco when they ran into a problem with MNK and chose to ignore the issue to pursue a failed acquisition.

Do they or do they not have an issue with US sales - if not why not present the bottles sold for January and February? An already skiddish group of shareholders and you want to do an M & A deal with a minimal amount of cash in the bank.
Bullboard Posts